Showing results (21-30 of 1,875) with videos related to
Sort By:
Pageof 188
Cellular Immunology|April 1, 1989
Elevated NK-mediated lysis of Raji and Daudi cells carrying fixed iC3b fragmentsO F Ramos, B Nilsson, K Nilsson, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1989
Lymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targetsO F Ramos, I Algarra, G Sármay, et al.International Journal of Cancer|September 15, 1977
Membrane receptor stripping confirms the association between EBV receptors and complement receptors on the surface of human B lymphoma linesE Yefenof, G KleinInternational Journal of Cancer|September 15, 1982
High- and low-leukemogenic variants of the radiation leukemia virus (RadLV) differ in ability to induce tumor-specific immune suppressionE Yefenof, D ZilchaNature|February 21, 1985
Interferon amplifies complement activation by Burkitt's lymphoma cellsE Yefenof, I McConnellCancer Immunology, Immunotherapy : CII|January 1, 1983
Suppressor and reactive lymphocytes in radiation leukemia virus (RadLV)-induced leukemogenesisE Yefenof, Y Ben-DavidLeukemia Research|January 1, 1986
Immunity and suppression in radiation- and radiation leukemia virus (RadLV)-induced leukemogenesisE Yefenof, Y Ben-DavidImmunology Letters|June 1, 1993
Mitogenic activation of phosphoinositide turnover and DNA synthesis in murine CD4+8+ thymocytesR Guy, E Yefenof, Y ZilbermanThe Journal of Experimental Medicine|December 1, 1980
In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesisE Yefenof, A Meidav, E KedarPageof 188